Related references
Note: Only part of the references are listed.Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer
Daniel J. Schaid et al.
EUROPEAN UROLOGY (2021)
Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations
Valentina Vysotskaia et al.
CANCER (2020)
Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1
Zhenyao Chen et al.
CELL DEATH & DISEASE (2020)
mTOR-regulated U2af1 tandem exon splicing specifies transcriptome features for translational control
Jae-Woong Chang et al.
NUCLEIC ACIDS RESEARCH (2019)
Function, clinical application, and strategies of Pre-mRNA splicing in cancer
Cuixia Di et al.
CELL DEATH AND DIFFERENTIATION (2019)
CADD: predicting the deleteriousness of variants throughout the human genome
Philipp Rentzsch et al.
NUCLEIC ACIDS RESEARCH (2019)
Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer
Veronica Mollica et al.
CELLS (2019)
Current progress and questions in germline genetics of prostate cancer
William B. Isaacs et al.
ASIAN JOURNAL OF UROLOGY (2019)
Overexpression of miR-101 May Target DUSP1 to Promote the Cartilage Degradation in Rheumatoid Arthritis
Yan Ye et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2019)
A Review of Prostate Cancer Genome-Wide Association Studies (GWAS)
Sarah Benafif et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher et al.
NATURE GENETICS (2018)
The emerging clinical relevance of genomics in cancer medicine
Michael F. Berger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer
Paula Paulo et al.
PLOS GENETICS (2018)
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
Yusuke Shiozawa et al.
NATURE COMMUNICATIONS (2018)
Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer
Ke Chen et al.
CLINICAL CANCER RESEARCH (2017)
Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes
Danielle M. Karyadi et al.
ONCOTARGET (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Impact of the G84E variant on &ITHOXB13&IT gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours
Liesel M. FitzGerald et al.
SCIENTIFIC REPORTS (2017)
Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition
Ola Rizq et al.
CLINICAL CANCER RESEARCH (2017)
The contribution of rare variation to prostate cancer heritability
Nicholas Mancuso et al.
NATURE GENETICS (2016)
Reciprocal negative feedback loop between EZH2 and miR-101-1 contributes to miR-101 deregulation in hepatocellular carcinoma
Da Huang et al.
ONCOLOGY REPORTS (2016)
Essential role of miRNAs in orchestrating the biology of the tumor microenvironment
Jamie N. Frediani et al.
MOLECULAR CANCER (2016)
Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown
Mihaela Pertea et al.
NATURE PROTOCOLS (2016)
Reducing the search space for causal genetic variants with VASP
Matthew A. Field et al.
BIOINFORMATICS (2015)
An integrative approach to predicting the functional effects of non-coding and coding sequence variation
Hashem A. Shihab et al.
BIOINFORMATICS (2015)
More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk
Samantha L. Rosenthal et al.
NEUROBIOLOGY OF AGING (2015)
Genome-wide association study identifies peanut allergy-specific loci and evidence of epigenetic mediation in US children
Xiumei Hong et al.
NATURE COMMUNICATIONS (2015)
Reliably Detecting Clinically Important Variants Requires Both Combined Variant Calls and Optimized Filtering Strategies
Matthew A. Field et al.
PLOS ONE (2015)
The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer
Jacob B. Hjelmborg et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
c-Myc-Mediated Epigenetic Silencing of MicroRNA-101 Contributes to Dysregulation of Multiple Pathways in Hepatocellular Carcinoma
Lei Wang et al.
HEPATOLOGY (2014)
A general framework for estimating the relative pathogenicity of human genetic variants
Martin Kircher et al.
NATURE GENETICS (2014)
A highly expressed miR-101 isomiR is a functional silencing small RNA
Franc Llorens et al.
BMC GENOMICS (2013)
Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility
Liesel M. FitzGerald et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Evaluating Power and Type 1 Error in Large Pedigree Analyses of Binary Traits
Anna C. Cummings et al.
PLOS ONE (2013)
Functional characterization of EZH2β reveals the increased complexity of EZH2 isoforms involved in the regulation of mammalian gene expression
Adrienne Grzenda et al.
EPIGENETICS & CHROMATIN (2013)
Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction
Jian Ye et al.
BMC BIOINFORMATICS (2012)
Confirmation of the HOXB13 G84E Germline Mutation in Familial Prostate Cancer
Joan P. Breyer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
A687V EZH2 is a gain-of-function mutation found in lymphoma patients
Christina R. Majer et al.
FEBS LETTERS (2012)
Germline Mutations in HOXB13 and Prostate-Cancer Risk
Charles M. Ewing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
Martin Sauvageau et al.
CELL STEM CELL (2010)
Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1
Phillippa C. Oakford et al.
LEUKEMIA RESEARCH (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Polycomb Group Protein Enhancer of Zeste 2 Is an Oncogene That Promotes the Neoplastic Transformation of a Benign Prostatic Epithelial Cell Line
Breanne D. W. Karanikolas et al.
MOLECULAR CANCER RESEARCH (2009)
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Francois-Olivier Desmet et al.
NUCLEIC ACIDS RESEARCH (2009)
Rapid generation of splicing reporters with pSpliceExpress
Shivendra Kishore et al.
GENE (2008)
Both β-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer
Ryutaro Mori et al.
PROSTATE (2008)
Case-control association testing with related individuals: A more powerful quasi-likelihood score test
Tirnothy Thornton et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Mutation screen and association study of EZH2 as a susceptibility gene for aggressive prostate cancer
N Bachmann et al.
PROSTATE (2005)
Genomic scan of 254 hereditary prostate cancer families
M Janer et al.
PROSTATE (2003)
Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis
JP Rubio et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Merlin-rapid analysis of dense genetic maps using sparse gene flow trees
GR Abecasis et al.
NATURE GENETICS (2002)
Share Paper
